Fonte: World Journal of Nuclear Medicine. Nome do evento: Congress of World Federation of Nuclear Medicine & Biology. Unidade: FM
Assuntos: NEOPLASIAS DA TIREOIDE, RADIOATIVIDADE ARTIFICIAL, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Jose W. et al. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 23 out. 2025. , 2006APA
Carvalho, J. W., Guimarães, M. I. C., Stabin, M. G., Malvestiti, L. F., Sapienza, M., Sordi, G. M. A. A., et al. (2006). Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo.NLM
Carvalho JW, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. 2006 ; 5 S48.[citado 2025 out. 23 ]Vancouver
Carvalho JW, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. 2006 ; 5 S48.[citado 2025 out. 23 ]
